Search details
1.
Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemia.
Blood
; 141(17): 2114-2126, 2023 Apr 27.
Article
in English
| MEDLINE | ID: mdl-36720090
2.
Patient values in patient-provider communication about participation in early phase clinical cancer trials: a qualitative analysis before and after implementation of an online value clarification tool intervention.
BMC Med Inform Decis Mak
; 24(1): 32, 2024 Feb 02.
Article
in English
| MEDLINE | ID: mdl-38308286
3.
Realizing better doctor-patient dialogue about choices in palliative care and early phase clinical trial participation: towards an online value clarification tool (OnVaCT).
BMC Palliat Care
; 18(1): 106, 2019 Nov 29.
Article
in English
| MEDLINE | ID: mdl-31783851
4.
Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study.
Clin Cancer Res
; 30(1): 50-62, 2024 01 05.
Article
in English
| MEDLINE | ID: mdl-37939124
5.
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial.
Nat Med
; 30(1): 271-278, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38052910
6.
Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study.
J Clin Oncol
; 41(36): 5536-5549, 2023 Dec 20.
Article
in English
| MEDLINE | ID: mdl-37651655
7.
Decisional Conflict after Deciding on Potential Participation in Early Phase Clinical Cancer Trials: Dependent on Global Health Status, Satisfaction with Communication, and Timing.
Cancers (Basel)
; 14(6)2022 Mar 15.
Article
in English
| MEDLINE | ID: mdl-35326653
8.
Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment.
Clin Cancer Res
; 28(7): 1402-1411, 2022 04 01.
Article
in English
| MEDLINE | ID: mdl-35046062
9.
Hypoxic regulation of metastasis via hypoxia-inducible factors.
Curr Mol Med
; 8(1): 60-7, 2008 Feb.
Article
in English
| MEDLINE | ID: mdl-18289014
10.
Cancer Therapy-Related Cardiac Dysfunction of Nonanthracycline Chemotherapeutics: What Is the Evidence?
JACC CardioOncol
; 1(2): 280-290, 2019 Dec.
Article
in English
| MEDLINE | ID: mdl-34396190
11.
Methylation of the TWIST1 promoter, TWIST1 mRNA levels, and immunohistochemical expression of TWIST1 in breast cancer.
Cancer Epidemiol Biomarkers Prev
; 17(12): 3325-30, 2008 Dec.
Article
in English
| MEDLINE | ID: mdl-19064546
12.
Conditional inactivation of HIF-1 using intrabodies.
Cell Oncol
; 30(5): 397-409, 2008.
Article
in English
| MEDLINE | ID: mdl-18791271
13.
Efficient target-selected mutagenesis in Caenorhabditis elegans: toward a knockout for every gene.
Genome Res
; 17(5): 649-58, 2007 May.
Article
in English
| MEDLINE | ID: mdl-17416746
14.
Identification by phage display of single-domain antibody fragments specific for the ODD domain in hypoxia-inducible factor 1alpha.
Lab Invest
; 86(4): 345-56, 2006 Apr.
Article
in English
| MEDLINE | ID: mdl-16482104
Results
1 -
14
de 14
1
Next >
>>